This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Zhejiang Meton Pharmaceutical Co., Ltd. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Jinlong Zhu: Innovator in Pharmaceutical Development
Introduction
Jinlong Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Jinlong Zhu holds a patent for an ISO-citrate dehydrogenase (IDH) inhibitor. This patent discloses compounds that inhibit the conversion of α-KG to D-2-HG, along with pharmaceutically acceptable salts, hydrates, solvates, or stereoisomers thereof. The pharmaceutical compositions comprising these compounds are designed to effectively treat IDH-associated diseases, including cancer. He has 1 patent to his name.
Career Highlights
Jinlong Zhu is currently employed at Zhejiang Meton Pharmaceutical Co., Ltd. His role at the company allows him to leverage his expertise in pharmaceutical development and contribute to innovative treatments that can improve patient outcomes.
Collaborations
Jinlong Zhu has collaborated with notable colleagues, including Jibin Yang and Feng Yan. These partnerships enhance the research and development efforts within the pharmaceutical sector.
Conclusion
Jinlong Zhu's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the area of IDH inhibitors, highlight the importance of research in developing effective treatments for serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile